BIO-key International, Inc (BKYI) Fair Value & Analysis
Industrials · US · Market cap $4.2M
BIO-key International, Inc
BKYI · US
Fair value as of: Jul 24, 2026
From 3 valuation models · updated 17 days ago
Share price −24.1% over the past month.
Below-average quality, screening 167% undervalued on our models.
What matters now
- The large discount to fair value meets weak quality (29/100). That raises the risk this is a value trap rather than a bargain.
- The price is below even our cautious bear case ($4.84). The market is more pessimistic than our downside scenario.
- The model range is unusually wide ($4.84 to $18.61). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 24, 2026.
How to read this chart
60‑month range $3.46 – $739.80 · fair‑value band $4.84 – $18.61 · the $4.03 price screens below the $10.77 fair value. Dashed = 300-day average. As of Jul 24, 2026.
Analysis
BIO-key International, Inc (BKYI) currently trades at $4.03, while our model-based Fair Value estimate is $10.77, implying the stock looks roughly 167.2% undervalued today. The Quality Score stands at 29/100 (below-average quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.
Over the trailing twelve months, BIO-key International, Inc generated revenue of $6.6M at a net margin of -60.6%. Revenue grew 33.5% year over year. It earns a return on equity of -53.7%. The balance sheet holds a net cash position of $2.6M. Fundamentals as of Jul 24, 2026
Our scenario range runs from $4.84 (bear case) to $18.61 (bull case); at $4.03, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 71% below its 52-week high and 30% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at 10% fair-value upside, at 167%, BKYI screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 3 models by family
Widest divergence: Dividend Discount ($6.43) versus Asset-Based ($4.73). Highest evidence: Gordon GGM (70).
Notify me when BKYI reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 24, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 33 · Market factors (momentum, volatility) 19
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education sectors in the United States and internationally.
Full company description
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education sectors in the United States and internationally. It offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premise SaaS application, services, and cloud host, as well as windows device authentication through IAM platform. The company's solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and civil and large-scale ID infrastructure solutions that develop finger-based biometric technology. Further, the company offers finger scanners for enterprise and consumer markets under SideSwipe, PIV Pro, EcoID II, and SidePass brand names; and fingerprint readers. Additionally, it provides identity and access management, user multi-factor authentication, and privilege entitlement and access control solutions. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
BIO-key International, Inc reported revenue of $6.1M in FY2025 versus $5.1M in FY2021, a compound +4.5%/yr. Reported net income was −$4.6M in FY2025.
Watch BKYI: get an alert when its fair value changes →
Peer Group
Security & Protection Services · 114 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Security & Protection Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Security & Protection Services stocks, each showing price versus our Fair Value estimate (as of Jul 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| ASSA ABLOY AB ASSAB | kr 348.40 | kr 269.97 | -23% |
| Verisure plc VSURE | €10.26 | €12.40 | +21% |
| Allegion plc ALLE | $137.24 | $127.80 | -7% |
| Securitas AB SECUB | kr 162.10 | kr 186.34 | +15% |
| Zhejiang Dahua Technology Co 002236 | ¥16.57 | ¥23.58 | +42% |
| MSA Safety Incorporated MSA | $169.00 | $118.51 | -30% |
| ADT Inc ADT | $7.06 | $17.10 | +142% |
| The Brink's Company BCO | $104.24 | $101.84 | -2% |
| Brady Corporation BRC | $90.16 | $73.43 | -19% |
| The GEO Group GEO | $29.46 | $32.36 | +10% |
Compare BIO-key International, Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is BIO-key International, Inc (BKYI) overvalued or undervalued?
What is the fair value of BKYI?
What is the quality score of BKYI?
What is the revenue of BIO-key International, Inc (BKYI)?
What is the net profit margin of BKYI?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track BIO-key International, Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.